| Dr Carrie Ann Timko, MD | |
|
610 High St, Lock Haven, PA 17745-3018 | |
| (570) 748-1260 | |
| (570) 748-1261 |
| Full Name | Dr Carrie Ann Timko |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 610 High St, Lock Haven, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447228978 | NPI | - | NPPES |
| 0019516580003 | Medicaid | PA | |
| 1491762 | Other | PA | HIGHMARK BLUE SHIELD |
| 2517559 | Other | PA | UNITEDHEALTHCARE |
| 816893 | Other | PA | FIRST PRIORITY HEALTH |
| 0019516580004 | Medicaid | PA | |
| 002990 | Other | PA | FIRST PRIORITY HEALTH |
| 68257 | Other | PA | GEISINGER HEALTH PLAN |
| H80791 | Other | PA | HEALTHAMERICA |
| 7306468 | Other | PA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD420479 (Pennsylvania) | Primary |
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD420479 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Susquehanna Home Care And Hospice Services | Williamsport, PA | Home health agency |
| Williamsport Regional Medical Center | Williamsport, PA | Hospital |
| Bucktail Medical Center | Renovo, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Geisinger Jersey Shore Hospital | Jersey shore, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Susquehanna Physician Services | 2264336460 | 492 |
News Archive
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
Authorities in Hong Kong say a wild oriental magpie robin found dead ten days ago has tested positive for the deadly H5N1 strain of the bird flu virus.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
› Verified 6 days ago
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205870904 PECOS PAC ID: 2264336460 Enrollment ID: O20040225000410 |
News Archive
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
Authorities in Hong Kong say a wild oriental magpie robin found dead ten days ago has tested positive for the deadly H5N1 strain of the bird flu virus.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
› Verified 6 days ago
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992743868 PECOS PAC ID: 2264336460 Enrollment ID: O20040412001371 |
News Archive
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
Authorities in Hong Kong say a wild oriental magpie robin found dead ten days ago has tested positive for the deadly H5N1 strain of the bird flu virus.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
› Verified 6 days ago
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972548337 PECOS PAC ID: 2264336460 Enrollment ID: O20040426001371 |
News Archive
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
Authorities in Hong Kong say a wild oriental magpie robin found dead ten days ago has tested positive for the deadly H5N1 strain of the bird flu virus.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carrie Ann Timko, MD 1201 Grampian Blvd, Suite 1k, Williamsport, PA 17701-1900 Ph: () - | Dr Carrie Ann Timko, MD 610 High St, Lock Haven, PA 17745-3018 Ph: (570) 748-1260 |
News Archive
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
Authorities in Hong Kong say a wild oriental magpie robin found dead ten days ago has tested positive for the deadly H5N1 strain of the bird flu virus.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
› Verified 6 days ago
David Luo, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Outlet Ln Ste 400, Suite 400, Lock Haven, PA 17745 Phone: 570-769-1300 | |
Dr. Amit Mehta, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 Bellefonte Ave, Lock Haven, PA 17745 Phone: 570-748-7714 Fax: 570-893-6325 | |
Dr. Mary Elizabeth Piergallini, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 High St, Lock Haven, PA 17745 Phone: 570-747-7400 Fax: 570-748-8004 | |
Sarah Mcelroy, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 High St, Lock Haven, PA 17745 Phone: 570-748-1260 | |
Shannon Seeland, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 68 Spring St, Lock Haven, PA 17745 Phone: 800-230-4565 Fax: 570-893-6325 | |
Dr. Boris Gabinskiy, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 955 Bellefonte Ave, Lock Haven, PA 17745 Phone: 570-748-7714 Fax: 570-893-6325 | |
Dr. Laura May Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 High St, Lock Haven, PA 17745 Phone: 570-748-1260 Fax: 570-748-1261 |